28 August 2009
FLUIDIGM has announced it will provide a status update on its ground-breaking Stem Cell Chip at the World Stem Cell Summit in Baltimore, Maryland, USA, due to take place 21 to 23 September 2009.
The Stem Cell Chip is expected to be available to the market next year.
The World Stem Cell Summit hopes to bring together the stem cell universe of researchers, ReGEN industry leaders, funders, medical philanthropies, policy-makers, advocates, educators and regulators to chart the future of regenerative medicine.
Organizers say the comprehensive, multi-track program will cover advanced science, commercial perspectives, disease progress reports and in-depth reviews of policy, law, ethics, regulatory issues and global economic development.
Fluidigm says historically, gene expression profiling of single cells, such as stem cells, has been difficult and expensive to perform. The company believes results from single-cell samples can be obtained easily and inexpensively using BioMark System and the company's Dynamic Array integrated fluidic circuits (IFCs).
Fluidigm claims Dynamic Array IFCs are ideally suited for high-throughput cell-line studies to determine individual cell behaviour in a homozygous population.